Aim/hypothesis-Immune mechanisms have been proposed to play a role in the development of diabetic neuropathy. We employed in vivo corneal confocal microscopy (CCM) to quantify the presence and density of Langerhans cells (LCs) in relation to the extent of corneal nerve damage in Bowman s layer of the cornea in diabetic patients.
Introduction
The dominant antigen presenting cells in the cornea and ocular surface are Langerhans cells (LCs) and Dendritic cells (DCs) which are derived from the bone marrow and can stimulate both primary and secondary T and B-cell responses [1] . The function and migration of DCs and LCs has been defined in numerous studies [2] . Dendritic cells were first described in the cornea by Engelmann in 1867, and have been thought to be present only in the periphery of the cornea in conditions associated with immune dysfunction such as herpetic keratitis [3, 4] , pseudomonas keratitis [5] and corneal allograft rejection [6] . However, recent ex vivo studies have confirmed the presence of LCs in the epithelial layer of the cornea and DCs in the anterior stroma of the central cornea [7] , and revised the belief that the cornea is immune privileged and indeed is able to respond to foreign antigens and auto antigens.
Corneal confocal microscopy provides a non-invasive means to readily demonstrate LCs in healthy subjects [8] [9] [10] and dendritic cells in patients with herpes keratitis [11] and mixed bacterial keratitis [12, 13] . Additionally, a range of stimuli causing corneal irritation including hypoxia, mechanical irritation, and inflammation have also been shown to lead to maturation and migration of LCs. Thus contact lens wear increases LCs and this has been demonstrated both ex vivo [14] and using corneal confocal microscopy in vivo [15] . Another recent study using corneal confocal microscopy in subjects after removal of metal foreign bodies has also shown an increase in the number of langerhans cells in relation to acute corneal injury [16] .
Over the past several years we have employed corneal confocal microscopy (CCM) to demonstrate that corneal nerve damage is directly related to the severity of somatic neuropathy in diabetic patients [17] [18] [19] and in patients with Fabry disease [20] . We have also shown repair of corneal nerves six months after pancreas transplantation in patients with Type 1 diabetes [21] . We have therefore suggested that this technique may be useful for non-invasively quantifying nerve damage and repair in diabetic and perhaps other neuropathies [22] . These observations also suggest that common mechanisms may be operative in the pathogenesis of corneal and peripheral nerve damage in diabetic patients. The underlying basis for corneal nerve damage is not established. With regard to diabetic neuropathy the Rochester cohort study [23] showed that the development of neuropathy was associated with poorer glycaemic control and the development of microvascular complications. A number of metabolic risk factors such as glucose, lipids, blood pressure and BMI have also been shown to be related to the development of diabetic neuropathy [24] [25] [26] . A unifying mechanism for the development of diabetic complications has been proposed [27] but remains to be substantiated in man [28] .
We have previously demonstrated that an immune mediated mechanism may act in concert with hyperglycemia to damage sensory and autonomic neurones [29] . Of relevance to the present study in the early 1980s, it was proposed that autoimmunity might contribute to the pathogenesis of diabetic neuropathy based on an association between diabetic autonomic neuropathy and iritis [30] . Since iritis itself is an immune mediated disorder with circulating immune complexes, it was suggested that the associated small fiber damage, which results in autonomic neuropathy, might have been due to autoimmunity. Thus it is of interest that using CCM an increase in the number of highly reflective cells "presumably dendritic cells" has been demonstrated in the cornea of patients with diabetes [31] .
The purpose of the present study was to quantify the presence and density of LCs in Bowman's layer in relation to the severity of corneal nerve damage and the severity of somatic neuropathy in a large group of diabetic patients and healthy subjects.
Method Neuropathy evaluation
This study was approved by Central Manchester Ethics Committee and written informed consent was obtained according to the Declaration of Helsinki. All patients underwent a detailed clinical history and examination. If the patients had neuropathy for any other reason apart from diabetes or had history of contact lens wear or corneal surgery they were excluded from the study. The neuropathy deficit score (NDS) was used to grade the severity of neuropathy. NDS is based on a clinical scoring system obtained from a neurological examination which defines abnormalities of vibration perception using a tuning fork, pin prick perception and temperature perception as well as the presence or absence of ankle reflexes, producing a score ranging from 0-10 [32] . Based on the NDS score, diabetic patients were classified into the following four groups: NDS = 0-2: 'no neuropathy'; NDS = 3-5: 'mild neuropathy'; NDS = 6-8: 'moderate neuropathy'; and NDS = 9-10: 'severe neuropathy'.
Corneal sensitivity
Corneal sensitivity was quantified using a non contact corneal aesthesiometer (NCCA) (Glasgow, Caledonian University, UK) which uses a puff of air on the centre of the cornea, lasting 0.9 seconds and exerting a force expressed in millibars (mbars) [33] . The coefficient of variation for NCCA is 5.6%.
Corneal Confocal Microscopy
Patients underwent examination with a Tomey Confoscan corneal confocal microscope model P4 (Erlangen, Germany). One eye of each subject was selected at random for examination. Several scans of the entire depth of the cornea were recorded by turning the fine focus of the objective lens backwards and forwards for approximately 2 min to acquire satisfactory images of all corneal layers providing en face two dimensional images with a lateral resolution of approximately 1 to 2 μm and final image size of 768 pixels × 576 pixels. On average, three to five high quality images of Bowman's layer were used to quantify both nerve fibre morphology and Langerhan cell density in all patients and control subjects and the average results of all these images calculated. This layer is of particular relevance for defining neuropathic changes since it is the location of the main nerve plexus that supplies the overlying corneal epithelium. The investigator who examined the cornea with the corneal confocal microscope and undertook morphometric measurements of the images was masked with respect to the identity of the patient. For morphometric measurements of corneal nerves four parameters were quantified [17] [18] [19] 34] : Corneal nerve fiber density (NFD) -total number of major nerves/mm 2 ; nerve fiber length (NFL) -total length of all nerve fibers and branches (mm/mm 2 ); nerve branch density (NBD) -number of branches emanating from major nerve trunks/mm 2 and nerve fibre tortuosity (NFT) was computed using a novel mathematical approach which was termed "tortuosity coefficient" (TC).
As anatomically Bowman's layer is an otherwise acellular layer containing c-nerve fibres, it is easy to distinguish other cells in this layer of the cornea. First, the presence or absence of highly reflective cells was assessed and then the number of highly reflective cells "langerhans cells" (Fig. 1) were counted manually in each image frame from Bowman's layer of the cornea in diabetic patients and healthy volunteers and the final density was derived as the number of cells in the area of frame assessed in square millimetres (number/ mm 2 ) [10] .
Statistical Analysis SPSS 11.05.0 for Windows was used to compute the results. Analysis included descriptive and frequency statistics. One-way analysis of variance (ANOVA) with Scheffe Post-hoc tests was used to study differences between means. Pearson test was used to analyze correlations between potentially related variables.
Results

Clinical details
128 predominantly Type 2 diabetic patients aged 58 ± 1 yrs with a mean duration of diabetes 15 ± 1 yrs were studied. The patients were stratified in accordance with the severity of somatic neuropathy using the NDS score: none (1.29 ± 0.14, n= 42), mild (3.86 ± 0.11, n=37), moderate (7.17 ± 0.19, n= 24) and severe (9.72 ± 0.09, n=25) and compared to 26 age-matched control subjects (53 ± 3 yrs). The age, type of diabetes and HbA1c were well matched between the different groups with differing severity of neuropathy. Diabetes duration and as expected the NDS increased with increasing neuropathic severity ( Table 1) .
Langerhans cells
The proportion of individuals with LCs was significantly increased in diabetic patients (73.8%) compared to control subjects (46.1%), P=0.001. Furthermore LC density was significantly increased in diabetic patients compared to control subjects (17.73 ± 1.45 v 6.94 ± 1.58 no/mm 2 , P=0.001) (Table 1, Figure 2 ). With regard to the severity of neuropathy, LC density was significantly increased in diabetic patients with no neuropathy (P=0.04) and mild neuropathy (P=0.004). However with progression of nerve damage, diabetic patients with moderate (P=0.393) and severe (P=0.932) neuropathy showed a reduction in the LC density which was not significantly different from control subjects (Table 2, Figure 2 ). There was no significant difference between patients with Type 1 and Type 2 diabetes, with LCs being present in 68% of patients with Type I and 72% of patients with Type 2 diabetes. The LC density was significantly increased in Type I (P=0.03) and Type 2 (P=0.009) diabetic patients compared to control subjects but did not differ between Type 1 (18.93 ± 3.85 no/mm 2 ) and Type 2 (17.48 ± 1.57 no/mm 2 ) diabetic patients.
Corneal Sensation
There was a progressive increase in the NCCA threshold indicative of a decrease in corneal sensation with increasing severity of neuropathy in diabetic patients (Table 1) .
Corneal Nerve Fibres
Corneal nerve fibre density (P<0.001), branch density (P<0.001) and length (P<0.001) were significantly decreased whilst tortuosity (P<0.01) was increased in diabetic patients with increasing severity of neuropathy (Table 1) .
Correlations
Despite the reduction in LCs in those with more severe neuropathy there was a significant correlation between the density of LCs and severity of neuropathy assessed by NDS (r= −0.02, P=0.02). There was also a significant correlation between LC density and age (r=0.162, P=0.04). There was no significant correlation between LC density and duration of diabetes (r=−0.082, P=0.36), or HbA1c (r=0.145, P=0.09). Gender had no effect on the number of LCs. In this group of patients, there was also a significant correlation between NDS and NFD (r=−0.341, P=0.000), NBD (r=−0.311, P=0.000), NFL (r=−0.430, P=0.000), NFT (r=0.217, P=0.02) and NCCA (r=0.414, P=0.000). However, there was no significant correlation between LC density and corneal sensitivity or corneal nerve morphology.
Discussion
The key finding is that the density of LCs was significantly increased in diabetic patients, particularly in those with no or mild neuropathy which then decreased in those with moderate and severe neuropathy, though still remained above control values. This suggests that LCs may play a role in the early phase of nerve damage and then this is maintained by other established mechanisms [28] . However, as there was no correlation between glycaemic control (HbA1c) and LC density this suggests that the increase in these cells may be a hyperglycemia independent mechanism. Although one might expect for there to be greater immune mediated involvement in patients with Type 1 diabetes, a sub analysis between patients with Type 1 and Type 2 diabetes showed no significant difference in LC density. We also confirm in a larger group of diabetic patients our previous observations demonstrating a progressive loss of corneal sensation [33] and abnormalities in corneal nerve morphology [17, 18, 34] .
Several in vivo studies have suggested that 'bright irregular particles' [35] , 'undefined dendritic structures' [11] and cellular structures [10, 15] represent LCs in the cornea. Thus using corneal confocal microscopy LCs are seen as bright corpuscular particles with DC morphology and a diameter of up to 15 μm [15] . An in vitro study using confocal microscopy on the corneal epithelium of mice has demonstrated the phenotype and distribution of MHC class II negative LCs in the central and paracentral areas, with MHC class II positive LCs in the limbus and corneal periphery [36] . They have been found to be mainly located in the periphery suggesting that there was lack of dendritic cells in the centre [37] . Most previous in vivo studies [10, 11, 35] have reported the location of the LCs to be beneath the basal epithelial cells between the nerve fibres, as in our study.
Studies of LCs in diabetes are limited using CCM with one study showing an increase in the number of highly reflective presumably "dendritic cells" in the cornea of diabetic patients [31] . To our knowledge, the present study is the first in vivo study identifying LCs in the Bowman's layer of the cornea of diabetic patients. Differentiating LC bodies lacking dendrites from LCs with small dendritic processes forming a local network, and LCs forming 'wire netting' via long interdigitating dendrites in Bowman's layer of the cornea using the Tomey light Confoscan is difficult [38] and this may explain some of the discrepancies in terms of the densities of LCs. The presence of LCs in 47% of healthy subjects is in agreement with Zhiviov et al, [10, 15] who showed that 31% of their normal cases had LCs. Also in the present study LCs were absent in 28% of diabetic patients and in 53% of control subjects which was similar to that in diabetic patients with severe neuropathy (52%). Although the presence of LCs is in agreement with a previous study [10] , the density of LCs is much lower in our study compared to other studies. This clearly reflects alternative means of detecting LCs, thus using in vitro techniques of immunofluorescence to detect HLA-DR antigens surface densities of LCs vary from 15-20 cells/mm 2 in the peripheral cornea of guinea pigs and rats to 50-100 cells/mm 2 and 75-150 cells/mm 2 in the peripheral cornea of mice and humans, respectively [39] . In vivo CCM has shown an average value of approximately 98 cells/mm 2 in the periphery of the cornea, and 34 cells/mm 2 in the central cornea of the human. Our lower values may reflect the fact that we focused principally on Bowman's layer which is known to have a lower density of LCs compared to the epithelial layer [36, 39] . In addition we employed the Tomey CCM which has been shown to underestimate LC density compared to newer CCMs such as the Heidelberg HRT III CCM [10, 15] .
In conclusion these data provide support for a potential immune mediated basis of corneal nerve damage. Given our previous studies showing a correlation between corneal and intraepidermal nerve fibre loss in diabetic patients [37] this provides further support for a common immune mediated mechanism for human diabetic neuropathy and adds to the body of previous data suggesting an immune component in the pathogenesis of human diabetic neuropathy [29, 30] . In the future the use of more powerful in vivo confocal microscopes such as the HRT-II may help further differentiate the role of LCs in the development and progression of nerve damage in diabetes. Furthermore, mechanistic studies are warranted to define the basis of this immune mediated damage to perhaps help develop therapeutic strategies to prevent early nerve fibre damage. Images from Bowman's layer of the cornea with highly reflective cells "presumably Langerhans cells". (a) control subject (b) diabetic patient with mild neuropathy (c) diabetic patient with severe neuropathy. Density of Langerhans cells (a) in diabetic patients compared to control subjects (P=0.001) (b) in diabetic patients according to severity of neuropathy (control v none P=0.045, v mild P=0.004, v moderate: P=0.393, v severe: P=0.932) (c) comparing patients with type I and type II diabetes. (For each group, horizontal bars illustrate the mean and vertical bars illustrate the SE.) Table 1 Demographic details, LC density, corneal sensation and CCM morphology in (a) diabetic patients and control subjects. 
